Company Overview
- Website
- cellevolve.com
- Phone
- (650) 880-6311
- Employees
- 9
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Recent News & Media
CE-VST01-JC: a Novel Allogeneic T-cell Based Immunotherapy for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) (PL4.002)
- Dec 18, 2023
- neurology.org
Seattle Children's spins out BrainChild Bio, a startup developing therapies for incurable brain cancers
- Dec 5, 2023
- geekwire.com
Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief
- Nov 3, 2023
- fiercebiotech.com
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
- Nov 1, 2023
- prnewswire.com
Cellevolve Bio Receives FDA Clearance of IND Application and Orphan Drug Designation for CE-VST01-JC for the Treatment of Progressive Multifocal Leukoencephalopathy (PML)
- Oct 25, 2022
- biospace.com
Cellevolve Announces Expansive Global Collaboration with Seattle Children’s Therapeutics to Advance Research for Childhood Brain Cancers
- Mar 9, 2022
- businesswire.com
Companies Similar to Cellevolve Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Cellevolve Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |